- Home
- NVVE vs BGLC Comparison
NVVE vs BGLC Comparison
Compare NVVE & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- BGLC
- Stock Information
- Founded
- NVVE 1996
- BGLC 2017
- Country
- NVVE United States
- BGLC Malaysia
- Employees
- NVVE N/A
- BGLC N/A
- Industry
- NVVE Oil Refining/Marketing
- BGLC Medical Specialities
- Sector
- NVVE Energy
- BGLC Health Care
- Exchange
- NVVE Nasdaq
- BGLC Nasdaq
- Market Cap
- NVVE 5.5M
- BGLC 5.0M
- IPO Year
- NVVE N/A
- BGLC N/A
- Fundamental
- Price
- NVVE $0.88
- BGLC $2.71
- Analyst Decision
- NVVE
- BGLC
- Analyst Count
- NVVE 0
- BGLC 0
- Target Price
- NVVE N/A
- BGLC N/A
- AVG Volume (30 Days)
- NVVE 2.8M
- BGLC 69.9K
- Earning Date
- NVVE 08-12-2025
- BGLC 08-13-2025
- Dividend Yield
- NVVE N/A
- BGLC N/A
- EPS Growth
- NVVE N/A
- BGLC N/A
- EPS
- NVVE N/A
- BGLC N/A
- Revenue
- NVVE $5,440,777.00
- BGLC $9,265,870.00
- Revenue This Year
- NVVE $892.33
- BGLC N/A
- Revenue Next Year
- NVVE N/A
- BGLC N/A
- P/E Ratio
- NVVE N/A
- BGLC N/A
- Revenue Growth
- NVVE N/A
- BGLC N/A
- 52 Week Low
- NVVE $0.82
- BGLC $2.01
- 52 Week High
- NVVE $8.80
- BGLC $8.40
- Technical
- Relative Strength Index (RSI)
- NVVE 42.76
- BGLC 43.64
- Support Level
- NVVE $1.22
- BGLC $2.60
- Resistance Level
- NVVE $1.54
- BGLC $3.06
- Average True Range (ATR)
- NVVE 0.16
- BGLC 0.21
- MACD
- NVVE -0.04
- BGLC -0.06
- Stochastic Oscillator
- NVVE 9.73
- BGLC 16.27
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.